Mary Downes Gastrich1,2, Stavros Zinonos1, Gloria Bachmann2, Nora M Cosgrove1, Javier Cabrera1,3, Jerry Q Cheng1, John B Kostis1. 1. Rutgers Robert Wood Johnson Medical School, Cardiovascular Institute of New Jersey, New Brunswick, New Jersey. 2. Department of Ob/Gyn and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey. 3. Department of Statistics and Biostatics, Rutgers University, New Brunswick, New Jersey.
Abstract
Background: Preeclampsia (PE) may lead to maternal and infant mortality and severe medical complications. Understanding future short- and long-term cardiovascular (CV) outcomes of PE is important to women's health. Materials and Methods: A retrospective matched case-control study assessed the risks of CV outcomes over a 15-year period (1999-2013) in pregnant case women, with gravidity and parity of one, diagnosed with PE, compared to pregnant primiparous control women who were not diagnosed with PE. The New Jersey Electronic Birth Certificate (EBC) database and the Myocardial Infarction Data Acquisition System (MIDAS), a database of all hospital admissions in New Jersey with longitudinal follow-up, were used to conduct the analysis. Participants were 18 years and older with demographics consistent with New Jersey, a state with a range of racial and ethnic diversity. Main outcome measures postpregnancy and over this 15-year period were myocardial infarction (MI), stroke, CV death, and all-cause death. Results: Women with PE (N = 6,360) were more likely to suffer MI, stroke, CV death, and all-cause death than controls (N = 325,347). After matching cases to controls for demographics and comorbidities, hazard ratios of PE cases for the outcomes of MI (p adjusted for comorbidities and demographics = 0.0196), CV death (adjusted p = 0.007), and all-cause death (adjusted p = 0.0026) were significantly higher than 1 compared to matched controls. Women with PE had 3.94 (95% CI: 1.25-12.4) times higher hazard for MI, 4.66 (95% CI: 1.52-14.26) times higher hazard of CV death, and 2.32 (95% CI: 1.34-4.02) times higher hazard for all-cause death than matched controls. Conclusions: This 15-year study indicates that women who have PE with their first pregnancy have a significantly higher risk of adverse CV outcomes compared to controls and suggest a heightened and continued CV monitoring after birth for this population of women.
Background: Preeclampsia (PE) may lead to maternal and infant mortality and severe medical complications. Understanding future short- and long-term cardiovascular (CV) outcomes of PE is important to women's health. Materials and Methods: A retrospective matched case-control study assessed the risks of CV outcomes over a 15-year period (1999-2013) in pregnant case women, with gravidity and parity of one, diagnosed with PE, compared to pregnant primiparous control women who were not diagnosed with PE. The New Jersey Electronic Birth Certificate (EBC) database and the Myocardial Infarction Data Acquisition System (MIDAS), a database of all hospital admissions in New Jersey with longitudinal follow-up, were used to conduct the analysis. Participants were 18 years and older with demographics consistent with New Jersey, a state with a range of racial and ethnic diversity. Main outcome measures postpregnancy and over this 15-year period were myocardial infarction (MI), stroke, CV death, and all-cause death. Results:Women with PE (N = 6,360) were more likely to suffer MI, stroke, CV death, and all-cause death than controls (N = 325,347). After matching cases to controls for demographics and comorbidities, hazard ratios of PE cases for the outcomes of MI (p adjusted for comorbidities and demographics = 0.0196), CV death (adjusted p = 0.007), and all-cause death (adjusted p = 0.0026) were significantly higher than 1 compared to matched controls. Women with PE had 3.94 (95% CI: 1.25-12.4) times higher hazard for MI, 4.66 (95% CI: 1.52-14.26) times higher hazard of CV death, and 2.32 (95% CI: 1.34-4.02) times higher hazard for all-cause death than matched controls. Conclusions: This 15-year study indicates that women who have PE with their first pregnancy have a significantly higher risk of adverse CV outcomes compared to controls and suggest a heightened and continued CV monitoring after birth for this population of women.
Authors: Lauren H Theilen; Philip Greenland; Jasmina Varagic; Janet Catov; Anthony Shanks; Vanessa Thorsten; Corette B Parker; Rebecca McNeil; Brian Mercer; Matthew Hoffman; Ronald Wapner; David Haas; Hyagriv Simhan; William Grobman; Judith H Chung; Lisa D Levine; Shannon Barnes; Noel Bairey Merz; George Saade; Robert M Silver Journal: Pregnancy Hypertens Date: 2022-02-04 Impact factor: 2.494
Authors: Eduardo Carvalho de Arruda Veiga; Paulo Ricardo Higassiaraguti Rocha; Leonardo L Caviola; Viviane Cunha Cardoso; Fabricio da Silva Costa; Maria da Conceição Pereira Saraiva; Marco Antonio Barbieri; Heloisa Bettiol; Ricardo Carvalho Cavalli Journal: Clinics (Sao Paulo) Date: 2021-01-20 Impact factor: 2.365
Authors: José Pacheco-Romero; Oscar Acosta; Doris Huerta; Santiago Cabrera; Marlene Vargas; Pedro Mascaro; Moisés Huamán; José Sandoval; Rudy López; Julio Mateus; Enrique Gil; Enrique Guevara; Nitza Butrica; Diana Catari; David Bellido; Gina Custodio; Andrea Naranjo Journal: Colomb Med (Cali) Date: 2021-02-26
Authors: Michael C Wang; Priya M Freaney; Amanda M Perak; Philip Greenland; Donald M Lloyd-Jones; William A Grobman; Sadiya S Khan Journal: J Am Heart Assoc Date: 2021-08-25 Impact factor: 5.501
Authors: Lauren H Theilen; Rebecca B McNeil; Shannon Hunter; William A Grobman; Corette B Parker; Janet M Catov; Victoria L Pemberton; Deborah B Ehrenthal; David M Haas; Matthew K Hoffman; Judith H Chung; Farhana Mukhtar; Zorayr Arzumanyan; Brian Mercer; Samuel Parry; George R Saade; Hyagriv N Simhan; Ronald J Wapner; Robert M Silver Journal: Am J Perinatol Date: 2021-08-06 Impact factor: 3.079